9th-Feb-2012 15:50Source: BSE

Dishman Pharma- Limited Review for Dec 31, 2011

Dishman Pharmaceuticals and Chemicals Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended December 31, 2011.

9th-Feb-2012 14:07Source: NSE

Dishman Pharmaceuticals and Chemicals Limited

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2011.

9th-Feb-2012 13:55Source: BSE

Dishman Pharma- Financial Results for Dec 31, 2011

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE about the Financial Results for the period ended December 31, 2011.

17th-Jan-2012 10:12Source: NSE

Dishman Pharmaceuticals and Chemicals Limited

Dishman Pharmaceuticals And Chemicals Limited has informed the Exchange that Company's Wholly Owned Subsidiary company, namely Carbogen Amcis AG., Switzerland has acquired Creapharm Parenterals, a sub...

17th-Jan-2012 08:52Source: BSE

Dishman Pharma- Acquisition of Creapharm Parenterals

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that Company's Wholly Owned Subsidiary company, namely Carbogen Amcis AG., Switzerland has acquired Creapharm Parenterals, a subsidiary of Fr...

11th-Nov-2011 13:53Source: NSE

Dishman Pharmaceuticals and Chemicals Limited

Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended September 30,2011.

11th-Nov-2011 13:15Source: BSE

Dishman Pharma- Financial Results for Sep 30, 2011

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE about the Financial Results for the period ended September 30, 2011.

11th-Oct-2011 17:14Source: BSE

Dishman Pharma- Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997

Janmejay R Vyas has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE

11th-Oct-2011 17:14Source: BSE

Dishman Pharma- Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Janmejay R Vyas has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

11th-Oct-2011 17:14Source: BSE

Dishman Pharma- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Dishman Pharmaceuticals and Chemicals Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE: